HBsAg - Quantitative (CMIA) in Kukatpally Housing Board Colony, Hyderabad

Hepatitis B is a viral infection that causes liver inflammation and can lead to serious liver damage, cirrhosis, or even liver cancer in some cases. The virus spreads through contact with infected blood or body fluids. Those who are at higher risk of contracting Hepatitis B include healthcare workers, people who inject drugs, those who engage in unprotected sex, and newborns of infected mothers.

Symptoms of Hepatitis B

The following are the common symptoms of Hepatitis B:
1. Abdominal pain
2. Dark urine
3. Fever
4. Joint pain
5. Loss of appetite
6. Nausea and vomiting
7. Weakness and fatigue
8. Yellowing of skin and eyes (jaundice)

Test Procedure

To perform the HBsAg - Quantitative (CMIA) test, a small blood sample is taken from the patient’s vein in their arm using a sterile needle and syringe. At the lab, the blood sample is analysed for the presence of the Hepatitis B surface antigen (HBsAg). The test relies on chemiluminescence microparticle immunoassay (CMIA) technology, which measures the level of HBsAg in the blood.

Positive Diagnosis

If a patient receives a positive diagnosis of Hepatitis B, there are several options available, including antiviral medications, such as tenofovir or entecavir. These medications help to slow or stop the virus from replicating in the body, reducing the risk of liver damage and complications. Patients may also be advised to take steps to protect their liver, such as avoiding alcohol and certain medications that can damage the liver.

Opting for Tests on Apollo 24|7

Booking a test panel on Apollo 24|7 is simple and convenient. Patients can select the HBsAg - Quantitative (CMIA) panel from the website and choose a time slot that suits them best. With results delivered within 69 hours, patients can receive prompt and accurate diagnoses, facilitating timely treatment.

Benefits of Early Diagnosis

Early diagnosis of Hepatitis B can help to prevent liver damage and complications. The HBsAg - Quantitative (CMIA) panel is highly accurate, allowing for early detection of the virus. By identifying Hepatitis B early on, patients can take steps to protect their liver and manage their condition effectively.